Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
May 20, 2024	CORRESP	CORRESP	View HTML 0001804220-24-000020.pdf 0001804220-24-000020.xls
May 17, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000094.pdf 0001968202-24-000094.xls
May 17, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000093.pdf 0001968202-24-000093.xls
May 17, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000025.pdf 0001883850-24-000025.xls
May 15, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001973141-24-000258.pdf 0001973141-24-000258.xls
May 15, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000022.pdf 0001883850-24-000022.xls
May 14, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001973141-24-000254.pdf
May 09, 2024	UPLOAD	UPLOAD	View HTML 0000000000-24-005254.pdf
May 06, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000020.pdf 0001883850-24-000020.xls
May 03, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000018.pdf 0001883850-24-000018.xls

Data provided by Kaleidoscope.

Investors & Media